title: Occlusive ocular vascular disease and antiphospholipid antibodies.
authors.forename: C
authors.initials: C
authors.lastname: Tolosa-Vilella
authors.forename: J
authors.initials: J
authors.lastname: Ordi-Ros
authors.forename: R
authors.initials: R
authors.lastname: Jordana-Comajuncosa
authors.forename: A
authors.initials: A
authors.lastname: Selva-O'Callaghan
authors.forename: M
authors.initials: M
authors.lastname: Vilardell-Tarres
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000276:immunology*; D001779:Blood Coagulation Factors / Q000276:immunology; D002308:Cardiolipins / Q000276:immunology; D006801:Humans; D016682:Lupus Coagulation Inhibitor; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000276:immunology*; D012170:Retinal Vein Occlusion / Q000150:complications*; D013577:Syndrome
chemical_list: D001323:Autoantibodies; D001779:Blood Coagulation Factors; D002308:Cardiolipins; D016682:Lupus Coagulation Inhibitor; D010743:Phospholipids